PARP INHIBITOR
Clinical trials for PARP INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PARP INHIBITOR trials appear
Sign up with your email to follow new studies for PARP INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new weapon against deadly brain cancer
Disease control OngoingThis study is testing whether adding a new drug called olaparib to the standard radiation and chemotherapy treatment can better control aggressive brain tumors that cannot be fully removed by surgery. It aims to find the safest dose and see if this combination helps patients live…
Matched conditions: PARP INHIBITOR
Phase: PHASE1, PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists hunt for hidden weakness in lung cancer
Knowledge-focused OngoingThis study aims to understand how common a specific DNA repair problem is in people with a certain type of advanced lung cancer (EGFR-mutated NSCLC). Researchers will look at tissue samples from 100 patients to see if having this problem is linked to how patients fare and if it m…
Matched conditions: PARP INHIBITOR
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC